T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Selective Insurance
SIGI
$5.59B
| $8M | ﹤0.01% |
98,656
+25,141
| +34% | +$2.03M |
|
1277
American Financial Group
AFG
$12B
| $7.99M | ﹤0.01% |
54,811
+529
| +1% | +$70.2K |
|
1278
DaVita
DVA
$11.6B
| $7.98M | ﹤0.01% |
60,077
-9,324
| -13% | -$1.28M |
|
|
NBIS
1279
Nebius Group N.V.
NBIS
$69.3B
| $7.81M | ﹤0.01% |
69,578
| – | – |
|
1280
BorgWarner
BWA
$14B
| $7.72M | ﹤0.01% |
175,538
+11,705
| +7% | +$468K |
|
1281
Regal Rexnord
RRX
$11.5B
| $7.71M | ﹤0.01% |
53,759
+3,540
| +7% | +$522K |
|
1282
Fomento Económico Mexicano
FMX
$40B
| $7.71M | ﹤0.01% |
78,146
-2,854
| -4% | -$265K |
|
1283
SouthState Bank Corp
SSB
$10.8B
| $7.56M | ﹤0.01% |
76,431
+5,103
| +7% | +$501K |
|
1284
Wayfair
W
$13.9B
| $7.51M | ﹤0.01% |
84,113
+8,975
| +12% | +$657K |
|
1285
AGNC Investment
AGNC
$12.9B
| $7.45M | ﹤0.01% |
761,216
+110,037
| +17% | +$1.07M |
|
|
CFLT
1286
DELISTED
Confluent
CFLT
| $7.44M | ﹤0.01% |
375,710
-3,086,316
| -89% | -$64.5M |
|
|
FLG
1287
Flagstar Bank National Association
FLG
$5.9B
| $7.41M | ﹤0.01% |
641,588
+14,826
| +2% | +$176K |
|
1288
OFG Bancorp
OFG
$2.26B
| $7.35M | ﹤0.01% |
168,968
+23,024
| +16% | +$1.01M |
|
1289
Five Below
FIVE
$13.2B
| $7.34M | ﹤0.01% |
47,457
+3,683
| +8% | +$521K |
|
1290
Amphastar Pharmaceuticals
AMPH
$850M
| $7.34M | ﹤0.01% |
275,222
+1,934
| +0.7% | +$49.9K |
|
1291
Donaldson
DCI
$11.2B
| $7.31M | ﹤0.01% |
89,272
+5,131
| +6% | +$387K |
|
1292
Antero Resources
AR
$11.5B
| $7.3M | ﹤0.01% |
217,403
+15,376
| +8% | +$512K |
|
1293
CONMED
CNMD
$1.49B
| $7.27M | ﹤0.01% |
154,556
+1,270
| +0.8% | +$65.8K |
|
|
CSGS
1294
DELISTED
CSG Systems International
CSGS
| $7.26M | ﹤0.01% |
112,778
+50,959
| +82% | +$3.25M |
|
1295
Canadian Pacific Kansas City
CP
$81.5B
| $7.21M | ﹤0.01% |
96,746
-3,037
| -3% | -$232K |
|
1296
Braze
BRZE
$3.12B
| $7.2M | ﹤0.01% |
253,280
-653,550
| -72% | -$18.5M |
|
1297
UroGen Pharma
URGN
$2.39B
| $7.12M | ﹤0.01% |
356,615
-4,826
| -1% | -$86.7K |
|
|
CMA
1298
DELISTED
Comerica
CMA
| $7.06M | ﹤0.01% |
103,048
+5,758
| +6% | +$388K |
|
|
CNH
1299
CNH Industrial
CNH
$17.3B
| $6.95M | ﹤0.01% |
640,890
+46,635
| +8% | +$569K |
|
1300
California Water Service
CWT
$3.09B
| $6.95M | ﹤0.01% |
151,401
+3,247
| +2% | +$149K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.